WO2026143249 - TOPICAL COMPOSITIONS OF OPIOID RECEPTOR ANTAGONISTS AND USES THEREOF
National phase entry is expected:
Publication Number
WO/2026/143249
Publication Date
02.07.2026
International Application No.
PCT/US2025/061525
International Filing Date
29.12.2025
Title **
[English]
TOPICAL COMPOSITIONS OF OPIOID RECEPTOR ANTAGONISTS AND USES THEREOF
[French]
COMPOSITIONS TOPIQUES D'ANTAGONISTES DES RÉCEPTEURS OPIOÏDES ET LEURS UTILISATIONS
Applicants **
HAIRDAO PAYMENTS LLC
Inventors
TRAXLER, Aonia
Priority Data
63/739,377
27.12.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3126 | |
| EPO | Filing, Examination, Granting | 24376 | |
| Japan | Filing, Examination, Granting | 2911 | |
| South Korea | Filing, Examination, Granting | 3738 | |
| USA | Filing, Examination, Granting | 7710 |
Total:
41,861
Contact Us
Abstract[English]
The present disclosure relates in some aspects to compositions, such as pharmaceutical compositions for topical administration, which are useful for treating or preventing hair loss, hair graying, and dermatological conditions in a subject, such as comprising an opioid receptor antagonist, for example naltrexone. Also provided are kits comprising the compositions, and methods of using the compositions for treating or preventing hair loss, hair graying, and dermatological conditions.[French]
La présente divulgation concerne, sous certains aspects, des compositions, telles que des compositions pharmaceutiques destinées à l'administration topique, qui sont utiles pour traiter ou prévenir la perte de cheveux, le grisonnement des cheveux et des affections dermatologiques chez un sujet, comprenant par exemple un antagoniste des récepteurs opioïdes, tel que la naltrexone. Sont également fournis des kits comprenant les compositions, ainsi que des méthodes d'utilisation des compositions pour traiter ou prévenir la perte de cheveux, le grisonnement des cheveux et des affections dermatologiques.